Forecasting Multidimensional Poverty: South Africa’s Policy Design

By HEOR Staff Writer

April 1, 2024

Multidimensional Poverty Forecasting

Introduction:

South Africa is taking a novel approach to tackle poverty. Going beyond income deprivation, the new multidimensional poverty forecasting (MDP) model, provides valuable insights for policy design. The result is a policy instrument that may be employed to formulate anti-poverty measures and evaluate their effectiveness, taking into account variables beyond only the lack of income, such as education, health, and living conditions.

A Groundbreaking Multidimensional Poverty Forecasting

Poverty, in all its forms, is a complex issue. Traditional income-based measures often fall short in capturing its true scope. In response, Applied Development Research Solutions (ADRS) has recently published a report, Multidimensional Poverty: Future Proof with Linked Macro-Micro Modelling. This study presents a pioneering approach to predict and plan for future MDP in South Africa. This new strategy can improve anti-poverty measures and evaluate their impact from 2024 to 2030.

The Dynamic Innovation: DIMMSIM Model

The study employs the DIMMSIM (Dynamic Integrated Macro-Micro Simulation Model) developed by ADRS Global. This model integrates macro (national) and micro (individual/household) data, offering a comprehensive picture of poverty beyond income levels. This lets the model predict future economic trends and their effects on poverty indicators at the national and sub-national levels and by gender, race, and area. It also allows for dynamic simulations of various policy scenarios, offering valuable insights into the potential effectiveness of different anti-poverty strategies.

Robust Predictions for Effective Policy Design

The DIMMSIM model draws its data from the extensive South African General Household Survey. This survey encompasses over 125,000 individuals from nearly 62,000 families. The vastness of this dataset roots the model’s predictions in real-world data, enhancing the reliability of forecasts. The model predicts future poverty trends and assesses potential policy impacts. This tool equips policymakers to craft more targeted and efficient strategies to combat poverty.

South Africa Leading the Global Fight Against Poverty

With this forward-looking tool, South Africa is poised to lead the global fight against poverty. The model’s ability to integrate multidimensional poverty into policy dialogue, planning, healthcare and design has significant implications, not only for South Africa but also for achieving the Sustainable Development Goals.

Conclusion:

This innovative methodology for poverty forecasting signifies a substantial advancement in the global effort to combat poverty. By incorporating multidimensional poverty into policy formulation, South Africa is setting a precedent for more effective anti-poverty strategies. This could have profound implications for health economics, both in South Africa and globally. As poverty is a significant determinant of health outcomes, a more nuanced understanding of its dimensions could facilitate better resource allocation, improved health service delivery, and ultimately, enhanced population health. This could be a game-changer for health economists and policymakers worldwide, providing a more holistic perspective to drive health equity.

Reference url

Recent Posts

medtech market access strategy
Prioritizing a Comprehensive Medtech Market Access Strategy Through Stakeholder Engagement

By João L. Carapinha

June 9, 2026

An effective medtech market access strategy must begin at the concept stage by simultaneously addressing patient needs, clinical workflows, regulatory requirements, and payer expectations rather than defaulting to FDA clearance as the sole priority. Startups that ignore this broader view risk bui...
HIV Weekly Treatment Options
Potential for Advancements in HIV Weekly Treatment Options

By João L. Carapinha

June 9, 2026

HIV Weekly Treatment Options took a major step forward as Gilead and Merck reported that their investigational once-weekly combination of islatravir and lenacapavir successfully met the primary endpoint in two Phase 3 trials. The oral regimen maintained viral suppression in adults already control...
Tovorafenib clinical assessment
Tovorafenib Clinical Assessment Outcomes and Methodological Challenges

By João L. Carapinha

June 9, 2026

The Tovorafenib clinical assessment conducted under the EU Joint Clinical Assessment process has exposed critical shortcomings in the evidence base for treating BRAF-altered pediatric low-grade glioma. Despite the therapy’s potential, reviewers concluded that robust comparative data is absent for...